Annual Drug Patent Expiration for TARGINIQ
Targiniq is a drug marketed by Purdue Pharma Lp and included in one NDA. There are fifteen patents protecting this drug.
Drug patent litigation for TARGINIQ.
This drug has two hundred and sixty-five patent family members in forty-four countries.
The generic ingredient in TARGINIQ is naloxone hydrochloride; oxycodone hydrochloride. Additional details are available on naloxone hydrochloride; oxycodone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published as the new Patent expired for the Purdue Pharma drug TARGINIQ